Corcept Therapeutics
CORT
#2263
Rank
$8.55 B
Marketcap
$79.71
Share price
-0.25%
Change (1 day)
7.31%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of March 2026 : $9.63 Million USD

According to Corcept Therapeutics 's latest financial reports the company's total debt is $9.63 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$6.1 M-11.95%
2024-12-31$6.93 M4493.38%
2023-12-31$0.15 M-86.79%
2022-12-31$1.14 M117.3%
2021-12-31$0.52 M-79.38%
2020-12-31$2.55 M-26.29%
2019-12-31$3.46 M
2018-12-31N/A
2016-12-31$14.66 M-2.01%
2015-12-31$14.96 M58.8%
2014-12-31$9.42 M64.1%
2013-12-31$5.74 M116.72%
2012-12-31$2.65 M
2010-12-31N/A-100%
2009-12-31$0 M-62.5%
2008-12-31$0.01 M-44.83%
2007-12-31$0.02 M-30.95%
2006-12-31$0.04 M-22.22%
2005-12-31$0.05 M
2003-12-31$0.52 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$54.98 B 570,482.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$46.99 B 487,582.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$63.73 B 661,205.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$43.37 B 449,936.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$49.11 B 509,571.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$46.42 B 481,668.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
$0.33 B 3,334.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.30 B 3,083.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.43 B 14,838.26%๐Ÿ‡บ๐Ÿ‡ธ USA